Publications
Nanofluidic Digital PCR for KRAS Mutation Detection and Quantification in Gastrointestinal Cancer. Clinical chemistry. 2012;58(9):1332-41. Abstract
Narrowing the equity gap: the impact of organized versus opportunistic cancer screening in Catalonia (Spain). Journal of medical screening. 2011;18(2):87-90. Abstract
Network modeling links breast cancer susceptibility and centrosome dysfunction. Nature genetics. 2007;39(11):1338-49.
The new advisory board of Gaceta Sanitaria is launched . Gaceta sanitaria / S.E.S.P.A.S. 2012;26(5):395-6.
Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes. European journal of human genetics : EJHG. 2012. Abstract
Nicotine depedence and salivary cotinine concentration in daily smokers. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP). 2012;21(1):96-102. Abstract
No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations. British journal of cancer. 2011;104(4):735-40. Abstract
Novel methylation panel for the early detection of colorectal tumors in stool DNA. Clinical colorectal cancer. 2010;9(3):168-76. Abstract
Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients. Inflammatory bowel diseases. 2012. Abstract
A novel similarity-measure for the analysis of genetic data in complex phenotypes. BMC bioinformatics. 2009;10 Suppl 6:S24. Abstract
Novel SLC7A7 large rearrangements in lysinuric protein intolerance patients involving the same AluY repeat. European journal of human genetics : EJHG. 2009;17(1):71-9. Abstract
Nt-proBNP in haemodialysis patients: a preliminary study. Scandinavian journal of clinical and laboratory investigation. 2008;68(5):415-20. Abstract
Obstetric history and mammographic density: a population-based cross-sectional study in Spain (DDM-Spain). Breast cancer research and treatment. 2012. Abstract
"Omics" research, monetization of intellectual property and fragmentation of knowledge: can clinical epidemiology strengthen integrative research? Journal of clinical epidemiology. 2007;60(12):1220-5; discussion 1226-8. Abstract
Oncogenic KRAS is not necessary for Wnt signalling activation in APC-associated FAP adenomas. The Journal of pathology. 2010;221(1):57-67. Abstract
Optimal cut-point of salivary cotinine concentration to discriminate smoking status in the adult population in Barcelona . Gaceta sanitaria / S.E.S.P.A.S. 2009;23(6):501-5. Abstract
Participation rates in the selection of population controls in a case-control study of colorectal cancer using two recruitment methods. Gaceta sanitaria / S.E.S.P.A.S. 2011;25(5):353-6. Abstract
Past medical conditions and K-ras mutations in pancreatic ductal adenocarcinoma: a hypothesis-generating study. Cancer causes & control : CCC. 2009;20(5):591-9. Abstract
Pathologic predictors of microsatellite instability in colorectal cancer. The American journal of surgical pathology. 2009;33(1):126-33.
Patterns of substance use in adolescents attending a mental health department. European child & adolescent psychiatry. 2011. Abstract
Pharmacogenetic approach for capecitabine or 5-fluorouracil selection to be combined with oxaliplatin as first-line chemotherapy in advanced colorectal cancer. European journal of cancer (Oxford, England : 1990). 2008;44(9):1229-37. Abstract
Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy. British journal of cancer. 2008;99(7):1050-5. Abstract
Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes. International journal of radiation oncology, biology, physics. 2011;81(5):1319-27. Abstract
